Nippon Kayaku Co., Ltd.

Tokyo Stock Exchange 4272.T

Nippon Kayaku Co., Ltd. Return on Equity (ROE) for the year ending March 31, 2024: 1.53%

Nippon Kayaku Co., Ltd. Return on Equity (ROE) is 1.53% for the year ending March 31, 2024, a -74.13% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • Nippon Kayaku Co., Ltd. Return on Equity (ROE) for the year ending March 31, 2023 was 5.90%, a -15.72% change year over year.
  • Nippon Kayaku Co., Ltd. Return on Equity (ROE) for the year ending March 31, 2022 was 7.00%, a 26.63% change year over year.
  • Nippon Kayaku Co., Ltd. Return on Equity (ROE) for the year ending March 31, 2021 was 5.53%, a -9.71% change year over year.
  • Nippon Kayaku Co., Ltd. Return on Equity (ROE) for the year ending March 31, 2020 was 6.12%, a -10.95% change year over year.
Key data
Date Return on Equity (ROE) Return on Capital Employed (ROCE) Interest Coverage Ratio Debt to Equity Ratio
Market news
Loading...
SV Wall Street
Tokyo Stock Exchange: 4272.T

Nippon Kayaku Co., Ltd.

CEO Mr. Atsuhiro Wakumoto
IPO Date Jan. 4, 2000
Location Japan
Headquarters Meiji Yasuda Seimei Building
Employees 5,902
Sector Health Care
Industries
Description

Nippon Kayaku Co., Ltd., together with its subsidiaries, develops, manufactures, and sells functional chemicals, pharmaceuticals, safety systems, and agrochemicals and other products in Japan and internationally. The company's Functional and Chemical Business segment offers functional materials, such as epoxy resins, UV-curable resins, sealants for LCD and LED, maleimide resins, photoresists and insulating materials for micro electromechanical systems, and cleaning agents and chemicals. This segment also provides color materials, including inkjet colorants, dyes for textiles and papers, and materials for thermal paper; catalysts for the production of acrylic and methacrylic acid; and polarizing films, inorganic polarizers, liquid crystal display components and projector parts, and components for x-ray analysis. Its Pharmaceuticals Business segment offers anti-cancer and cancer-related drugs, biosimilars, generic drugs, interventional radiology products, cardiovascular drugs, bulk drugs and intermediates of pharmaceuticals, and drugs for diagnosing cancer, as well as GlycoMark, a product as a marker of blood sugar control used for diabetes. The company's Safety Systems Business segment provides airbag inflators, micro gas generators for seatbelt pretensioners, and squibs. Its Agrochemicals Business segment offers agricultural insecticides, herbicides, soil fumigants, and insanitary insecticides. The company also engages in real estate leasing services. The company was formerly known as Nihon Kayaku Seizou Co., Ltd. and changed its name to Nippon Kayaku Co., Ltd. in 1945. Nippon Kayaku Co., Ltd. was incorporated in 1916 and is headquartered in Tokyo, Japan.

Similar companies

4208.T

UBE Corporation

USD 14.85

-1.00%

4183.T

Mitsui Chemicals, Inc.

USD 22.16

0.12%

4042.T

Tosoh Corporation

USD 13.44

0.58%

3401.T

Teijin Limited

USD 8.61

0.56%

4021.T

Nissan Chemical Corporation

USD 30.49

0.20%

StockViz Staff

January 31, 2025

Any question? Send us an email